28th March 2024
12th March 2024
28th February 2024
3rd April 2023
13th March 2023
13th March 2023
2nd March 2023
US - West Virginia: Senate Bill 220, which would create the Hemp-derived Cannabinoid Regulation Act, has just passed the Senate and now heads to the House. It would regulate the sale of hemp products that contain “naturally occurring non-synthetic, and unadulterated substances”, specifically including cannabinoids such as delta-8 THC, HHC, and THCV. The bill would further regulate hemp products by imposing labelling requirements, banning sales to under-21s, and imposing a 15% sales tax on retail sales, among other things.
2nd March 2023
US - West Virginia: Senate Bill 546 has just passed the Senate and now heads to the House. It would add delta-8 and delta-10 THC, THCO, and “synthetic and non-naturally occurring cannabinoids” as Schedule I substances but would exempt any substance or product that is lawfully produced under the state’s hemp law.
13th September 2022
US - West Virginia: A proposal to cap THC in medical cannabis products at 10% has been rejected by the Medical Cannabis Advisory Board – at least for the time being, press reports. The board said it needed more information before imposing any such cap. The board’s next meeting will be in January 2023.
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields